HBK Investments’s Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CRHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-70,300
Closed -$54K 760
2022
Q1
$54K Sell
70,300
-77,700
-53% -$55K ﹤0.01% 568
2021
Q4
$118K Buy
+148,000
New +$145K ﹤0.01% 574

Other funds holding CRHC.WS

HBK Investments's CRHC.WS Position: Q2 2022 in Review

HBK Investments sold out of Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CRHC.WS) in Q2 2022, closing a stake of 70,300 shares — an estimated $54K sold.

HBK Investments first reported a position in CRHC.WS in Q4 2021 and held it in 2 quarters. The position peaked at $118K in Q4 2021. 58 funds tracked by Wall St. Rank hold CRHC.WS as of Q2 2022.

  • HBK Investments reported no remaining Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • HBK Investments sold 70,300 Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $54K.
  • HBK Investments first reported a position in Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 2 quarters.
  • HBK Investments's Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $118K in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.